Key result
Combining a leadless pacemaker with a subcutaneous implantable cardioverter-defibrillator is presented as a therapeutic strategy.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ramandi et al. (2022) studied this question. Combining a leadless pacemaker with a subcutaneous implantable cardioverter-defibrillator is presented as a therapeutic strategy.
Synapse has enriched 10 related papers. Consider them for comparative context: